Uncategorized

Gene Therapies for Hearing Loss Strike an Encouraging Note in Embattled Modality

Published

2 weeks ago

on

Eli Lilly and Regeneron are leading the push to treat congenital deafness with gene therapies, seeking a piece of a potential billion-dollar market and banking on local delivery and the small amount of drug required to overcome key safety concerns.

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version